Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.

Allione, Attilio; Giamello, Jacopo Davide; Paglietta, Giulia; Bernardi, Sara; Cavalot, Giulia

Allione, Attilio; Giamello, Jacopo Davide; Paglietta, Giulia; Bernardi, Sara; Cavalot, Giulia.

Afiliación

Allione A; Department of Emergency Medicine, Santa Croce and Carle Hospital, Cuneo, Italy.
Giamello JD; School of Emergency Medicine, University of Turin, Turin, Italy. jacopo.giamello@gmail.com.
Paglietta G; School of Emergency Medicine, University of Turin, Turin, Italy.
Bernardi S; Department of Emergency Medicine, Santa Croce and Carle Hospital, Cuneo, Italy.
Cavalot G; Department of Emergency Medicine, Santa Croce and Carle Hospital, Cuneo, Italy.

Intern Emerg Med ; 16(2): 519-520, 2021 03.

Article en En | MEDLINE | ID: mdl-32440985

Asunto(s)

COVID-19; SARS-CoV-2; Anticoagulantes/efectos adversos; Antivirales/uso terapéutico; Heparina/efectos adversos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Intern Emerg Med Asunto de la revista: MEDICINA DE EMERGENCIA / MEDICINA INTERNA Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google